Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantifying the risk of SARS‐CoV‐2 reinfection over time
Éamon Ó Murchú, Paula Byrne, Paul G. Carty, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 1
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

The T cell immune response against SARS-CoV-2
Paul Moss
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 186-193
Open Access | Times Cited: 1087
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
Juliet R. C. Pulliam, Cari van Schalkwyk, Nevashan Govender, et al.
Science (2022) Vol. 376, Iss. 6593
Open Access | Times Cited: 838
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
Juliet R. C. Pulliam, Cari van Schalkwyk, Nevashan Govender, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 341
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
Caroline Stein, Hasan Nassereldine, Reed J D Sorensen, et al.
The Lancet (2023) Vol. 401, Iss. 10379, pp. 833-842
Open Access | Times Cited: 309
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 233
CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants
Zhi Chen, Chenshuo Wu, Yuxuan Yuan, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 130
The Emergence of Omicron: Challenging Times Are Here Again!
Tanu Singhal
The Indian Journal of Pediatrics (2022) Vol. 89, Iss. 5, pp. 490-496
Open Access | Times Cited: 99
Reinfection in patients with COVID-19: a systematic review
Xiangying Ren, Jie Zhou, Jing Guo, et al.
Global Health Research and Policy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 90
Risk and severity of SARS-CoV-2 reinfections during 2020–2022 in Vojvodina, Serbia: A population-level observational study
Snežana Medić, Cleo Anastassopoulou, Zagorka Lozanov-Crvenković, et al.
The Lancet Regional Health - Europe (2022) Vol. 20, pp. 100453-100453
Open Access | Times Cited: 79
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Jia Wei, Nicole Stoesser, Philippa C. Matthews, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
Mahesh B. Shenai, Ralph Rahme, Hooman Noorchashm
Cureus (2021)
Open Access | Times Cited: 72
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
Francesca Rovida, Irene Cassaniti, Stefania Paolucci, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 66
SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020–31 January 2023
Luca Cegolon, Greta Camilla Magnano, Corrado Negro, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1551-1551
Open Access | Times Cited: 28
Percentages of Vaccination Coverage Required to Establish Herd Immunity against SARS-CoV-2
Pedro Plans-Rubió
Vaccines (2022) Vol. 10, Iss. 5, pp. 736-736
Open Access | Times Cited: 34
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Modelling the unexpected dynamics of COVID-19 in Manaus, Brazil
Daihai He, Yael Artzy‐Randrup, Salihu S. Musa, et al.
Infectious Disease Modelling (2024) Vol. 9, Iss. 2, pp. 557-568
Open Access | Times Cited: 5
Leveraging Large Language Models to Study Infectious Diseases Based on Self-reporting Tweets: A Web Service to Monitor COVID-19 Trend (Preprint)
Jiacheng Xie, Ziyang Zhang, Shuai Zeng, et al.
Journal of Medical Internet Research (2025) Vol. 27, pp. e63190-e63190
Open Access
Influenza vaccine is able to induce post-infection antibodies to SARS-CoV-2 in medical staff
M. P. Kostinov, N. Yu. Nastaeva, N. F. Nikityuk, et al.
Medical Immunology (Russia) (2025) Vol. 27, Iss. 1, pp. 169-178
Open Access
Strategic Resource Management in Pandemics: Integrating Capacity Planning with Non-Pharmaceutical Interventions for Covid-19
Özlem Coşgun, Eyyüb Y. Kıbış, Ali Dağ, et al.
(2025)
Closed Access
Equivalency of Protection from Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
Mahesh B. Shenai, Ralph Rahme, Hooman Noorchashm
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 38
Vaccinating people who have had covid-19: why doesn’t natural immunity count in the US?
Jennifer Block
BMJ (2021), pp. n2101-n2101
Closed Access | Times Cited: 34
The unexpected dynamics of COVID-19 in Manaus, Brazil: Was herd immunity achieved?
Daihai He, Yael Artzy‐Randrup, Salihu S. Musa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 28
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
Qi Chen, Kongxin Zhu, Xiaohui Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 793-803
Open Access | Times Cited: 20
Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccines
Elham Jamshidi, Amirhossein Asgary, Paria Shafiekhani, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top